Taiwan clears VUNO's AI fundus analysis tool
South Korean firm VUNO has gained the approval of Taiwan's Food and Drug Administration to market its AI fundus analysis software.
VUNO Med-Fundus AI analyses images of the fundus to quickly detect locations of lesions indicative of retinal diseases, including diabetic retinopathy, macular disease and glaucoma.
This latest certification follows Taiwan...
Singapore clears VUNO's AI software for fundus analysis
South Korean medical AI firm VUNO has recently obtained a medical device certification from Singapore's Health Sciences Authority for its AI-based fundus analysis software.
The VUNO Med-Fundus AI analyses images of the fundus, which is the back part of the eye, to provide findings necessary for the diagnosis of retinal diseases. It can...
